Lupin receives ISRS certification from Det Norske Veritas

18 Oct 2013 Evaluate

Lupin has received certification for International Sustainability Rating Standard, 8th edition (ISRS) from Det Norske Veritas (DNV), a global provider of services for managing risk, helping customers to safely and responsibly improve their business performance. The certification was received after audits were conducted at three of the company's manufacturing facilities in India located at Ankleshwar, Mandideep and Tarapur. Lupin is the first pharmaceutical company globally to have received this ISRS 8th edition certification

ISRS is a world leading system to assess, improve and demonstrate the health of an organization's business processes. Using ISRS ensures operations are safe and sustainable and helps improve and demonstrate safety, environmental, and sustained business operations / performance.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×